[Dynamics of blood viscosity indices in patients with alcoholic myocardiodystrophy]

Terapevticheskii Arkhiv
|January 1, 1989
PubMed

Insights

This study shows that blood viscosity in alcoholic cardiomyopathy worsens with chronic alcoholism severity. Treatment effectiveness correlates with initial patient status, with Stage III patients showing persistent high blood viscosity.

Area of Science:

  • Cardiology
  • Toxicology
  • Hematology

Background:

  • Alcoholic cardiomyopathy is a significant complication of chronic alcoholism.
  • Understanding the impact of alcoholism on blood rheology is crucial for patient management.

Purpose of the Study:

  • To assess rheological blood parameters in patients with alcoholic cardiomyopathy across different stages of chronic alcoholism.
  • To evaluate the correlation between disease severity, treatment efficacy, and blood rheology.
  • To determine the long-term impact of alcoholism on blood viscosity.

Main Methods:

  • Examination of 120 patients with alcoholic cardiomyopathy (Stages I-III) and 25 healthy controls.
  • Measurement of rheological blood parameters: fluidity limit, apparent viscosity, red blood cell aggregation ratio, and hematocrit.
  • Longitudinal assessment of parameters before treatment, post-treatment, and one month after discharge.

Main Results:

  • Blood viscosity significantly increased with the severity of chronic alcoholism.
  • Treatment outcomes correlated with the initial condition of patients.
  • Patients with Stage I and II alcoholism showed normalization of parameters, while Stage III patients maintained elevated blood viscosity post-treatment.

Conclusions:

  • Rheological blood parameter monitoring can aid in assessing alcoholic cardiomyopathy severity.
  • Blood rheology assessment provides an additional method for evaluating treatment efficacy in alcohol-induced cardiovascular abnormalities.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...